The ophthalmology devices market size is projected to reach US$ 73.99 billion by 2031 from US$ 40.48 billion in 2023. The market is expected to register a CAGR of 7.83% in 2023–2031. The rising prevalence of ophthalmic disorders is likely to remain a key ophthalmology devices market trend.
Ophthalmic devices are designed for surgical, diagnostic, and vision correction purposes. These devices have gained substantial importance over the years due to the high incidence of cataracts, glaucoma, and other vision-related issues. Moreover, companies in the ophthalmology devices market are introducing technologically advanced contact lenses and spectacle lenses. The demand for ophthalmic diagnosis and monitoring devices is on the rise due to advancements in medical technologies, an upsurge in the prevalence of eye diseases caused by changing lifestyles, the increasing incidence of chronic diseases, and the burgeoning aging population. Advanced technologies such as artificial intelligence (AI), telemedicine, and the Internet of Things (IoT) play a pivotal role in eye screening procedures, thereby boosting operational efficiency, accuracy, cost-efficiency, and access to ophthalmic care.
Technological innovation has always been fundamental to any discipline of life sciences, including ophthalmology, as modern devices are key to accurate diagnosis and improved treatments. Advancements in medications, diagnostic devices, laser systems, and surgical techniques have enabled the improved diagnosis of glaucoma, cataracts and macular degeneration, and dry eye disease. Factors such as upsurge in the incidence of ophthalmic disorders, and increasing number of product launch, acquisition and collaboration is driving the market growth. In addition, technological advancements in ophthalmic devices is acting as an opportunity for the market. However, the high cost of ophthalmic surgeries is the major factor hindering the market growth.
Virtual reality, 3D imaging, and Big Data and artificial intelligence (AI) are being used for data analysis in ophthalmology. These tools have made it possible to gain accurate and reliable results. Tools such as AI are being used in the screening of diabetic retinopathy, lesion detection, and disease progress monitoring (e.g., progress of age-related macular degeneration or macular edema). However, these tools are still under development as they are being evaluated for their suitability in diagnostic and prognostic applications in ocular pathologies. Minimally invasive surgeries such as LASIK (i.e., laser-assisted in situ keratomileusis) surgery, femtosecond laser surgery, multi-wavelength diabetic retinopathy treatment, and ultrasound phacoemulsification are likely to increase the demand for ophthalmology devices, in turn, propelling the overall market growth.
Technological innovation has always been fundamental to any discipline of life sciences, including ophthalmology, as modern devices are key to accurate diagnosis and improved treatments. Advancements in medications, diagnostic devices, laser systems, and surgical techniques have enabled the improved diagnosis of glaucoma, cataracts and macular degeneration, and dry eye disease. Virtual reality, 3D imaging, and big data and artificial intelligence (AI) are being used for data analysis in ophthalmology. These tools have made it possible to gain accurate and reliable results. Tools such as AI are being used in the screening of diabetic retinopathy, detection of lesions, and monitoring of the progress of certain diseases such as age-related macular degeneration or macular edema. However, these tools are still under development as they are being evaluated for their suitability in diagnostic and prognostic applications in ocular pathologies. Minimally invasive surgeries such as LASIK (i.e., laser-assisted in situ keratomileusis) surgery, femtosecond laser surgery, multi-wavelength diabetic retinopathy treatment, and ultrasound phacoemulsification are likely to increase the demand for ophthalmology devices, in turn, propelling the overall market growth.
Key segments that contributed to the derivation of the ophthalmology devices market analysis are product, vision care devices, diagnostic and monitoring devices, surgical devices, application, and end user.
The geographic scope of the ophthalmology devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The market growth in North American region can be attributed to the rising prevalence of eye diseases such as glaucoma and cataracts, and the presence of major manufacturers in North American countries.
The regional trends and factors influencing the Ophthalmology Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Ophthalmology Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 40.48 Billion |
Market Size by 2031 | US$ 73.99 Billion |
Global CAGR (2023 - 2031) | 7.83% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The Ophthalmology Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Ophthalmology Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The ophthalmology devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the ophthalmology devices market are mentioned below:
The “Ophthalmology Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:
The List of Companies - Ophthalmology Devices Market
Factors such as the growing prevalence of ophthalmic disorders and the rising geriatric population prone to various eye disorders. However, the high cost of ophthalmic devices and lack of awareness related to these devices in developing countries hinder the ophthalmology devices market growth. Additionally, technological advancements are anticipated to bring new ophthalmology devices market trends in the coming years.
Ophthalmology devices are medical equipment used for vision correction, eye disease diagnosis, and surgical procedures. These devices include invasive devices such as implantable devices (intraocular lenses and glaucoma stents), and noninvasive diagnostic equipment and instruments. Key factors driving the market growth include the growing prevalence of ophthalmic disorders and the rising geriatric population prone to various eye disorders. However, the high cost of ophthalmic devices and lack of awareness related to these devices in developing countries hinder the ophthalmology devices market growth. Additionally, technological advancements are anticipated to bring new ophthalmology devices market trends in the coming years.
The ophthalmology devices market majorly consists of the players, including Johnson & Johnson Vision Care Inc., Alcon AG, Carl Zeiss Meditec, Bausch & Lomb Inc, Essilor International SAS, Nidek Co Ltd, Topcon Corp, Haag-Streit AG, Ziemer Ophthalmic Systems AG, and Hoya Corp.
The ophthalmology devices market was valued at US$ 40.48 billion in 2023.
The ophthalmology devices market is expected to be valued at US$ 73.99 billion in 2031.
Based on product, the ophthalmology devices market is divided into vision care devices, surgical devices, and diagnostic and monitoring devices. The vision care devices segment held the largest market share in 2023.
Based on application, the market is segmented into glaucoma, cataract, vitreoretinal disorder, refractory disorder, and others. The glaucoma segment held a major market share in 2023.
In terms of end user, the market is segmented into hospitals and eye clinics, academic and research laboratories, and others. The hospitals and eye clinics segment dominated the market in 2023.